Sanofi CEO Sees Double-Digit Growth In China In Next Five Years
This article was originally published in PharmAsia News
Executive Summary
Sanofi will grow annually by double digits over the next five years in China, the French drug maker's Chief Executive Christopher Viehbacher said, pointing to the 1 billion-plus euro ($1.28 billion) posted last year when sales rose 15%.